GPRD, DrugLogic enter data license agreement
DrugLogic’s Qscan product monitors patient, adverse event, claims, outcomes and publicly available data sources. As per the terms of the collaboration, GPRD will allow DrugLogic to format and
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.